Influenza vaccination cost saving for the elderly in TaiwanCost-effectivenessElderlyHospitalisationInfluenza-virus-infections, preventionInfluenza-virus-vaccine, therapeutic usePharmacoEconomics & Outcomes News -doi:10.1007/BF03279395NA;Springer International PublishingPharmacoEconomics & Outcomes News...
There is an unmet need for new influenza vaccine strategies that compensate for impaired vaccine responses in elderly individuals. Here, we evaluated the effectiveness of a single-stranded RNA (ssRNA) as an adjuvant to enhance the efficacy of inactivated influenza vaccine (IIV) in mouse models. Im...
Focuses on an article by Nichol, et al in the September 22, 1994 issue of the 'New England Journal of Medicine,' which deals with the use of influenza vaccine with elderly people. Comments on larger observational studies of the effectiveness of influenza vaccines in preventing the ...
Influenza vaccination programs for elderly persons: cost- effectiveness in a health maintenance organization. Ann Intern Med 1994; 121: 947-952... JP Mullooly - 《Annals of Internal Medicine》 被引量: 0发表: 1994年 Effectiveness of influenza vaccine in the community-dwelling elderly. Reliable est...
vaccineBACKGROUND: Vaccination coverage for influenza in the elderly remains low when the physician is the only person responsible for immunization. Integration of other health care workers may improve the coverage rate of at-risk groups. OBJECTIVES: To estimate vaccination coverage rate by using a ...
FLUAD® with MF59® Adjuvant is a flu vaccine designed to strengthen, broaden, and lengthen the duration of the immune response and is approved for patients 65+. Visit flu360.com to learn more.
We undertook this study to measure the influenza vaccine coverage in nursing and residential homes for elderly people in the Carmarthenshire region (UK) during the winter of 1998/99. We are not aware of a similar study in institutionalised elderly residents undertaken in the UK during the ...
Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly. Group for the Study of Prevention of CAP in the Elderly: Effectiveness of the Pneumococcal Polysaccharide Vaccine in Preventing Pneumonia in the Elderly. ERJ... A Dominguez,C Izquierdo,L Salleras,... -...
First, antibody protection that is provided by the vaccine decreases during the year following vaccination. Second, vaccines created for pre-existing viral strains may not work against new strains; nor does an infection with one flu strain confer immunity to infection by another strain.According to...
This is a serious failing, as elderly patients have the highest risk of morbidity and mortality from influenza infection. Accordingly, researchers are looking for new ways to improve the antigenicity of influenza vaccines in this subpopulation. The adjuvant MF-59 may be the answer, according to ...